Arena Pharmaceuticals, Inc. | TalkMarkets

Latest Posts

Small Caps - Long Term Consistent Outperformance

Article By: Tarun Chandra, CFA

Friday, November 10, 2017 6:35 PM EDT

Small cap stocks represent a segment that has consistently outperformed the larger caps over the long term. A portfolio should consider a stable and long-term allocation towards this segment.

In this article: KEM, KRO, WTW, ARNA, OSTK, QQQ, WPRT, DVAX, INSM, IWM, CHGG, ABEO, MRTX, GDS

Read

Biotech Investing Guide: 3 Stocks To Buy And 3 To Avoid

Article By: Arpita Dutt

Friday, March 11, 2016 2:10 PM EDT

Anyone interested in biotech stocks will know that it could be challenging to pick winners in this industry which is constantly growing and changing. We have zeroed in on 3 biotech stocks to buy and 3 to avoid.

In this article: ARNA, MNTA, REGN, AMGN, CELG, GILD Also: ABBV

Read

Arena Pharmaceuticals Announces Collaboration With Privately Held Boehringer Ingelheim

Article By: Terry Chrisomalis

Tuesday, January 12, 2016 6:37 PM EDT

Arena stands to make more than $250 million in milestone payments.

In this article: ARNA

Read

Arena Pharmaceuticals 1Q Loss Narrower-Than-Expected

Article By: Zacks Investment Research

Tuesday, May 12, 2015 6:27 AM EDT

Arena Pharmaceuticals, Inc. (ARNA) reported a first-quarter 2015 loss of 10 cents per share, narrower than the Zacks Consensus Estimate of a loss of 14 cents and the year-ago loss of 12 cents.

In this article: ARNA, ESALY Also: GILD, ALIOF

Read